Identity and weight verification
Further REIMAGINE results presented at the ADA meeting in June 2026 reinforced that signal across diverse patient groups
No est recomendada durante el embarazo sin supervisin mdica
People taking GLP-1 medications commonly report reduced food cravings, less emotional eating, and a quieting of the constant mental preoccupation with food that researchers call "food noise." Animal studies have also shown that GLP-1 receptor activation reduces the rewarding properties of high-calorie food in the brain findings confirmed in a landmark randomized, placebo-controlled neuroimaging study in humans ( van Bloemendaal et al., Diabetes, 2014 )
But, the female body needs hormonal balance of estrogen and testosterone, so GLP-1 drugs can interfere with the brains chemical messengers
Thyroid dysfunction, insulin resistance, hormonal imbalances, and chronic inflammation all contribute to stubborn weight